OBJECTIVE: To investigate whether Barrett's metaplasia may develop despite effective medical therapy. SUMMARY BACKGROUND DATA: Gastroesophageal reflux disease has a multifactorial etiology. Therefore, medical treatment may not prevent complications of reflux disease. METHODS: Eighty-three patients with reflux disease and mild esophagitis were prospectively studied for the development of Barrett's metaplasia while receiving long-term therapy with proton pump inhibitors and cisapride. Only patients who had effective control of reflux symptoms and esophagitis were included. The surveillance time was 2 years. The outcome of these 83 patients was compared with that of 42 patients in whom antireflux surgery was performed with a median follow-up of 3.5 years. RESULTS: Twelve (14.5%) patients developed Barrett's while receiving medical therapy; this was not seen after surgery. Patients developing Barrett's had a weaker lower esophageal sphincter and peristalsis before treatment than patients with uncomplicated disease. CONCLUSIONS: Antireflux surgery is superior to medical therapy in the prevention of Barrett's metaplasia. Therefore, patients with reflux disease who have a weak lower esophageal sphincter and poor esophageal peristalsis should undergo antireflux surgery, even if they have only mild esophagitis.
OBJECTIVE: To investigate whether Barrett's metaplasia may develop despite effective medical therapy. SUMMARY BACKGROUND DATA: Gastroesophageal reflux disease has a multifactorial etiology. Therefore, medical treatment may not prevent complications of reflux disease. METHODS: Eighty-three patients with reflux disease and mild esophagitis were prospectively studied for the development of Barrett's metaplasia while receiving long-term therapy with proton pump inhibitors and cisapride. Only patients who had effective control of reflux symptoms and esophagitis were included. The surveillance time was 2 years. The outcome of these 83 patients was compared with that of 42 patients in whom antireflux surgery was performed with a median follow-up of 3.5 years. RESULTS: Twelve (14.5%) patients developed Barrett's while receiving medical therapy; this was not seen after surgery. Patients developing Barrett's had a weaker lower esophageal sphincter and peristalsis before treatment than patients with uncomplicated disease. CONCLUSIONS: Antireflux surgery is superior to medical therapy in the prevention of Barrett's metaplasia. Therefore, patients with reflux disease who have a weak lower esophageal sphincter and poor esophageal peristalsis should undergo antireflux surgery, even if they have only mild esophagitis.
Authors: E C Klinkenberg-Knol; F Nelis; J Dent; P Snel; B Mitchell; P Prichard; D Lloyd; N Havu; M H Frame; J Romàn; A Walan Journal: Gastroenterology Date: 2000-04 Impact factor: 22.682
Authors: B Hallerbäck; P Unge; L Carling; B Edwin; H Glise; N Havu; E Lyrenäs; K Lundberg Journal: Gastroenterology Date: 1994-11 Impact factor: 22.682
Authors: E C Klinkenberg-Knol; H P Festen; J B Jansen; C B Lamers; F Nelis; P Snel; A Lückers; C P Dekkers; N Havu; S G Meuwissen Journal: Ann Intern Med Date: 1994-08-01 Impact factor: 25.391
Authors: H Wykypiel; T Kamolz; P Steiner; A Klingler; F A Granderath; R Pointner; G J Wetscher Journal: Surg Endosc Date: 2005-07-28 Impact factor: 4.584
Authors: A Perathoner; H Weiss; W Santner; G Brandacher; E Laimer; E Höller; F Aigner; A Klaus Journal: Obes Surg Date: 2008-06-28 Impact factor: 4.129
Authors: A Perathoner; H Weiss; W Santner; G Brandacher; E Laimer; E Höller; F Aigner; A Klaus Journal: Obes Surg Date: 2008-08-15 Impact factor: 4.129
Authors: Theodore Liakakos; George Karamanolis; Paul Patapis; Evangelos P Misiakos Journal: Gastroenterol Res Pract Date: 2009-12-31 Impact factor: 2.260